James S Tomlinson

Title: James S. Tomlinson: Innovator in Cancer Research

Introduction

James S. Tomlinson is a notable inventor based in Santa Monica, CA. He has made significant contributions to the field of cancer research, particularly in understanding inflammatory breast carcinoma. His work has implications for both diagnostic and therapeutic advancements in this challenging area of oncology.

Latest Patents

Tomlinson holds a patent titled "Human inflammatory breast carcinoma xenograft capable of lymphovascular invasion and methods for its use." This invention provides human transplantable inflammatory breast carcinoma xenografts that exhibit unique characteristics. These xenografts are essential for experimental models of inflammatory carcinoma, allowing researchers to dissect the molecular basis of this phenotype. The model can be utilized to identify molecular targets for therapeutic intervention and assess the efficacy of various diagnostic and therapeutic agents. Additionally, the patent outlines methods for diagnosing and inhibiting the growth of inflammatory breast cancer metastases in vivo.

Career Highlights

James S. Tomlinson is affiliated with the University of California, where he continues to advance research in cancer biology. His innovative approaches have garnered attention in the scientific community, contributing to a deeper understanding of inflammatory breast cancer.

Collaborations

Tomlinson has collaborated with esteemed colleagues such as Sanford H. Barsky and Mary L. Alpaugh. Their joint efforts have further enriched the research landscape in cancer studies.

Conclusion

James S. Tomlinson's work exemplifies the critical intersection of innovation and medical research. His contributions to understanding inflammatory breast carcinoma are paving the way for future advancements in cancer treatment.